CSPC Pharmaceutical Group Limited (CVG) — Cash Flow Reinvestment Rate

Latest as of September 2020: 0.39x

CSPC Pharmaceutical Group Limited (CVG) has a Cash Flow Reinvestment Rate of 0.39x as of September 2020, reinvesting €831.32 Million (capex €258.14 Million plus investments €-573.18 Million) from operating cash flow of €2.16 Billion. Explore CVG capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.39x
(Capex + Investments) / Operating CF

Total Reinvested

€831.32 Million
Capex + Investments

Operating Cash Flow

€2.16 Billion
EUR

Capital Expenditures

€258.14 Million
EUR

CSPC Pharmaceutical Group Limited Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for CSPC Pharmaceutical Group Limited across 13 annual periods. Also explore CVG current and non-current assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for CSPC Pharmaceutical Group Limited (2013–2025)

Year-by-year capital reinvestment analysis for CSPC Pharmaceutical Group Limited. For live market cap and broader valuation context, see CSPC Pharmaceutical Group Limited market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2025 0.74x €4.33 Billion €5.83 Billion €2.28 Billion ▼ -18.3%
2024 0.91x €4.12 Billion €4.53 Billion €2.68 Billion ▲ +51.9%
2023 0.60x €2.50 Billion €4.18 Billion €1.89 Billion ▼ -27.5%
2022 0.83x €6.30 Billion €7.63 Billion €2.22 Billion ▲ +87.5%
2021 0.44x €2.04 Billion €4.64 Billion €1.41 Billion ▲ +64.2%
2020 0.27x €1.81 Billion €6.74 Billion €1.36 Billion ▼ -52.7%
2019 0.57x €2.14 Billion €3.78 Billion €1.88 Billion ▼ -30.7%
2018 0.82x €3.10 Billion €3.80 Billion €1.67 Billion ▼ -7.3%
2017 0.88x €2.90 Billion €3.29 Billion €1.18 Billion ▲ +14.0%
2016 0.77x €2.25 Billion €2.92 Billion €1.06 Billion ▲ +101.0%
2015 0.38x €864.81 Million €2.25 Billion €815.69 Million ▼ -15.4%
2014 0.45x €820.58 Million €1.81 Billion €807.00 Million ▼ -40.6%
2013 0.77x €623.39 Million €814.86 Million €597.12 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow